J Korean Ophthalmol Soc > Volume 61(5); 2020 > Article |
|
Treatment time (hours) | Symbol | Fold regulation | p-value* |
---|---|---|---|
24 | CSPG5 | 1.9593 | 0.002 |
FGF11 | 1.4945 | 0.018 | |
FIGF | 2.7424 | 0.015 | |
GPI | 1.2497 | 0.017 | |
IL12B | 2.1265 | 0.022 | |
INHA | 1.5887 | 0.038 | |
NODAL | 1.8208 | 0.015 | |
SLCO1A2 | 2.0629 | <0.001 | |
48 | CSPG5 | 2.3975 | 0.002 |
FGF19 | 3.2913 | 0.035 | |
INHA | 1.7735 | 0.010 | |
NODAL | 2.0471 | 0.002 | |
NRTN | 1.3215 | 0.026 | |
72 | BMP6 | 2.9498 | 0.011 |
CSPG5 | 2.0076 | 0.004 | |
FGF9 | 4.9506 | 0.016 |
CSPG5 = chondroitin sulfate proteoglycan 5; FGF11 = fibroblast growth factor 11; FIGF = C-fos induced growth factor; GPI = glucose-6-phosphate isomerase; IL12B = interleukin 12B; INHA = inhibin, alpha; NODAL = nodal homolog; SLCO1A = solute carrier organic anion transporter family, member 1A2; NRTN = neurturin; BMP6 = bone morphogenetic protein 6.
Treatment time (hours) | Symbol | Fold Regulation | p-value* |
---|---|---|---|
24 | BDNF | -2.2171 | 0.033 |
BMP3 | -1.4162 | 0.025 | |
BMP5 | -14.1983 | 0.007 | |
DKK1 | -2.2101 | 0.024 | |
FGF1 | -5.3166 | <0.001 | |
FGF2 | -1.6152 | 0.034 | |
FGF5 | -2.3940 | 0.001 | |
GDNF | -2.4611 | 0.009 | |
HBEGF | -4.7389 | 0.001 | |
IL11 | -4.8919 | 0.001 | |
IL1B | -2.4053 | 0.004 | |
INHBA | -2.4999 | 0.001 | |
LIF | -3.0640 | 0.001 | |
NGF | -5.7235 | 0.001 | |
NRG1 | -3.5381 | <0.001 | |
NRG2 | -2.0963 | 0.001 | |
PTN | -2.1381 | 0.003 | |
48 | BDNF | -2.6076 | 0.023 |
BMP5 | -24.348 | 0.005 | |
CSF2 | -4.5479 | 0.015 | |
DKK1 | -3.6360 | 0.003 | |
FGF1 | -14.1946 | <0.001 | |
FGF2 | -1.8586 | 0.019 | |
FGF5 | -3.1228 | 0.001 | |
GDNF | -4.2029 | 0.003 | |
GPI | -1.2300 | 0.042 | |
HBEGF | -7.2166 | <0.001 | |
IL11 | -5.8300 | <0.001 | |
INHBA | -4.5339 | <0.001 | |
LIF | -3.8573 | <0.001 | |
NGF | -5.5075 | 0.001 | |
NRG1 | -5.4341 | <0.001 | |
NRG2 | -1.8586 | 0.044 | |
NRTN | 1.6124 | 0.026 | |
OSGIN1 | -2.4951 | 0.030 | |
PGF | -2.1297 | 0.013 | |
PTN | -1.9103 | 0.006 | |
SLCO1A2 | -1.7586 | 0.007 | |
TGFB1 | -1.5063 | 0.012 | |
VEGFC | -1.3886 | 0.005 | |
72 | BDNF | -2.6342 | 0.022 |
BMP1 | -2.4719 | 0.022 | |
BMP3 | -1.9116 | 0.017 | |
BMP5 | -14.7667 | 0.007 | |
CSF2 | -6.6266 | 0.011 | |
DKK1 | -3.4652 | 0.003 | |
FGF1 | -32.5026 | <0.001 | |
FGF2 | -2.6041 | 0.008 | |
FGF5 | -4.2442 | <0.001 | |
GDF11 | -2.9371 | 0.032 | |
GDNF | -5.6102 | 0.003 | |
GPI | -2.6866 | 0.012 | |
HBEGF | -16.5348 | <0.001 | |
IL11 | -6.6797 | <0.001 | |
IL1B | -3.0850 | 0.002 | |
INHBA | -5.4952 | <0.001 | |
LIF | -4.7370 | 0.001 | |
NGF | -6.2932 | 0.001 | |
NRG1 | -6.6517 | <0.001 | |
OSGIN1 | -3.3487 | 0.025 | |
PGF | -2.7404 | 0.020 | |
PTN | -2.8094 | 0.001 | |
TGFB1 | -2.1278 | 0.024 | |
VEGFC | -1.3467 | 0.006 |
BDNF = brain-derived neurotrophic factor; BMP = bone morphogenetic protein; DKK = dickkopf homolog; FGF = fibroblast growth factor; GDNF = glial cell derived neurotrophic factor; HBEGF = heparin-binding EGF-like growth factor; IL = interleukin; INHBA = inhibin, beta A; LIF = leukemia inhibitory factor; NGF = nerve growth factor; NRG = neuregulin; PTN = pleiotrophin; CSF = colony stimulating factor; GPI = glucose-6-phosphate isomerase; NRTN = neurturin; OSGIN = oxidative stress induced growth inhibitor; PGF = placental growth factor; SLCO1A2 = solute carrier organic anion transporter family, member 1A2; TGFB1 = transforming growth factor, beta 1; VEGFC = vascular endothelial growth factor C.
The Early Diagnosis of Herpetic Ke ratitis by Polymerase Chain Reaction.2001 January;42(1)